A cancer diagnosis is never easy, and one of the most common patient fears is chemotherapy. Bristol Myers Squibb’s new “Beyond Chemotherapy” awareness effort looks t...

As the pharmaceutical supply chain has grown more geographically diverse, drugmakers have leaned more and more on contract manufacturers to help carry the load....

Vidaza boasts a long-established place in conventional treatment for patients with acute myeloid leukemia (AML). Now, its active ingredient, azacitidine, has been sp...

A deadly pandemic isn't the time for leading U.S. health agencies to disagree on data and treatment benefits, but that's the situation playing out as new COVID-19 tr...

GlaxoSmithKline has a goal when it comes to vaccine awareness: Boost education enough so that when people turn 50, they recognize age-recommended vaccines as automat...

When FDA investigators identify potentially grave issues at a drug manufacturer's facility, the general assumption is that the company will do its best to remedy the...

As both summer and the pandemic wear on, pharma TV advertising may have settled into a groove. That is, TV spending came in slightly lower than usual year over year ...

After months of rumors, Takeda has finally unveiled a deal to sell its Japanese consumer health business to Blackstone Group. The U.S. private investment shop coul...

CRO opens new Oxford site in response to urgent demand from small and medium innovators for specialist scientific expertise Ghent (Belgium), 24 August 2020:  Europ...

Trialbee, a leading global technology provider for patient matching and engagement in clinical trials, today announced a partnership with Clinerion, a worldwide lead...